在慢性阻塞性肺部疾病中选潜在的关键铁亡相关基因
Yumeng Cao1, Huaqin Pan2, Yanwei Yang3
1Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|December 7, 2023
概括
这项研究使用生物信息学在慢性阻塞性肺部疾病 (COPD) 中确定了41个与铁亡相关的基因. 像HIF1A,PPARG和KRAS这样的关键基因可能会通过ferroptosis影响COPD的发展,提供潜在的治疗点.
科学领域:
- 生物医学研究的研究.
- 基因组学就是基因组学.
- 肺部病理学 肺部病理学
背景情况:
- 铁亡是一种受调节的细胞死亡途径,与慢性阻塞性肺病 (COPD) 病原发生有关.
- 了解COPD中铁亡的遗传基础对于开发新型治疗策略至关重要.
研究的目的:
- 通过全面的生物信息学分析,识别与COPD相关的潜在铁化相关基因.
- 探索COPD中这些已识别的基因的功能作用和调节网络.
主要方法:
- 利用了RNA测序数据 (GSE148004) 和铁病基因数据库 (FerrDb).
- 进行了差异表达分析,蛋白质-蛋白质相互作用 (PPI) 网络构建,基因本体学 (GO) 和基因和基因组 (KEGG) 京都百科全书的路径丰富分析.
- 构建了基因-微RNA (miRNA) 和基因-转录因子相互作用网络,并预测了潜在的治疗药物.
主要成果:
- 在COPD患者中与健康对照人群相比,确定了41个与ferroptosis相关的基因 (22个上调,19个下调) 的差异表达.
- 富化分析显示了与铁亡,癌症中的中央碳代谢和HIF-1信号通路的关联.
- 确定了关键基因,关键的miRNA,转录因子和潜在的治疗药物.
结论:
- 确定了41个与铁亡相关的基因作为COPD发展的潜在贡献者.
- 突出显示HIF1A,PPARG和KRAS作为可能调节COPD中铁亡的关键基因.
- 这些发现增强了对COPD病理生理学的理解,并建议针对铁亡的潜在治疗途径.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Cystic Fibrosis: Pathogenesis
252
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
252
COPD: Pathogenesis and Clinical Features
292
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
292
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K


